Global Hypertension Drugs Market 2016-2020
About Hypertension Drugs
Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension can be classified as:
• PAH
• Systemic hypertension (commonly referred to as hypertension)
PAH, high BP in the arteries that carry blood from the heart to the lungs, occurs when blood vessels narrow, making blood flow difficult. This creates pressure on the heart's right ventricle, which increases in size and becomes weaker due to the excess load, leading to heart failure. The normal pulmonary arterial pressure at rest is 14 mmHg and increases from 25 mmHg to 30 mmHg.
Systemic hypertension occurs when blood vessels that supply oxygenated blood to the body become narrower, creating pressure on the right side of the heart. Hypertension can lead to damaged organs and illnesses such as renal failure (kidney failure), aneurysm, heart failure, stroke, or heart attack. Hypertension is classified into two types:
• Primary or essential hypertension: It is defined as high BP with no known cause, and includes around 90%-95% of all hypertension cases
• Secondary hypertension: It is high BP with a known direct cause, including kidney disease, tumors, or birth control pills, and includes 5%-10% of all hypertension cases
Technavio’s analysts forecast the global hypertension drugs market to decline at a CAGR of (0.93) % during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hypertension drugs market for 201652020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent hypertension and pulmonary arterial hypertension (PAH).
The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC
Technavio's report, Global Hypertension Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Actelion Ltd.
• AstraZeneca plc
• Boehringer Ingelheim GmbH
• Daiichi Sankyo Company, Ltd.
• Novartis AG
• Sanofi SA
Other prominent vendors
• Actelion Pharmaceuticals
• Arena Pharmaceuticals
• Asahi Kasei
• Bayer HealthCare
• Bellerophon Therapeutics
• Bial
• CJ HealthCare
• Conatus Pharmaceuticals
• Daiichi Sankyo
• Deka Pharmaceuticals
• Dong-A ST
• Eiger BioPharmaceuticals
• Forest Laboratories
• Gilead Sciences
• HanAll BioPharma
• Hanmi Pharmaceutical
• Johnson & Johnson
• LG Life Sciences
• Lung Biotechnology
• Lupin Pharmaceuticals
• Mast Therapeutics
• Merck
• Northern Therapeutics
• Ono Pharmaceutical
• Pfizer
• PhaseBio
• Pluristem Therapeutics
• Quantum Genomics
• Radikal Therapeutics
• Reata Pharmaceuticals
• Serodus
• sigma-tau i.f.r
• SteadyMed Therapeutics
• Suda
• Sun Pharmaceutical Industries
• Symplmed Pharmaceuticals
• Takeda Pharmaceuticals
• United Therapeutics
• Valeant Pharmaceuticals
• XOMA
• Yuhan
Market driver
• Growing older population
• For a full, detailed list, view our report
Market challenge
• Patent expiries of major drugs
• For a full, detailed list, view our report
Market trend
• Increase in awareness
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension can be classified as:
• PAH
• Systemic hypertension (commonly referred to as hypertension)
PAH, high BP in the arteries that carry blood from the heart to the lungs, occurs when blood vessels narrow, making blood flow difficult. This creates pressure on the heart's right ventricle, which increases in size and becomes weaker due to the excess load, leading to heart failure. The normal pulmonary arterial pressure at rest is 14 mmHg and increases from 25 mmHg to 30 mmHg.
Systemic hypertension occurs when blood vessels that supply oxygenated blood to the body become narrower, creating pressure on the right side of the heart. Hypertension can lead to damaged organs and illnesses such as renal failure (kidney failure), aneurysm, heart failure, stroke, or heart attack. Hypertension is classified into two types:
• Primary or essential hypertension: It is defined as high BP with no known cause, and includes around 90%-95% of all hypertension cases
• Secondary hypertension: It is high BP with a known direct cause, including kidney disease, tumors, or birth control pills, and includes 5%-10% of all hypertension cases
Technavio’s analysts forecast the global hypertension drugs market to decline at a CAGR of (0.93) % during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hypertension drugs market for 201652020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent hypertension and pulmonary arterial hypertension (PAH).
The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC
Technavio's report, Global Hypertension Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Actelion Ltd.
• AstraZeneca plc
• Boehringer Ingelheim GmbH
• Daiichi Sankyo Company, Ltd.
• Novartis AG
• Sanofi SA
Other prominent vendors
• Actelion Pharmaceuticals
• Arena Pharmaceuticals
• Asahi Kasei
• Bayer HealthCare
• Bellerophon Therapeutics
• Bial
• CJ HealthCare
• Conatus Pharmaceuticals
• Daiichi Sankyo
• Deka Pharmaceuticals
• Dong-A ST
• Eiger BioPharmaceuticals
• Forest Laboratories
• Gilead Sciences
• HanAll BioPharma
• Hanmi Pharmaceutical
• Johnson & Johnson
• LG Life Sciences
• Lung Biotechnology
• Lupin Pharmaceuticals
• Mast Therapeutics
• Merck
• Northern Therapeutics
• Ono Pharmaceutical
• Pfizer
• PhaseBio
• Pluristem Therapeutics
• Quantum Genomics
• Radikal Therapeutics
• Reata Pharmaceuticals
• Serodus
• sigma-tau i.f.r
• SteadyMed Therapeutics
• Suda
• Sun Pharmaceutical Industries
• Symplmed Pharmaceuticals
• Takeda Pharmaceuticals
• United Therapeutics
• Valeant Pharmaceuticals
• XOMA
• Yuhan
Market driver
• Growing older population
• For a full, detailed list, view our report
Market challenge
• Patent expiries of major drugs
• For a full, detailed list, view our report
Market trend
• Increase in awareness
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
